Loading…
FMED and MTRA share 4.8% of their holdings.
| Side by side | FMED | MTRA |
|---|---|---|
| Strategy | Thematic · Disruptive tech | International · Ex-US broad |
| Expense ratio | 0.50% | 0.54% |
| Cost per year on $10k | $50 | $54 |
| Trailing 12-mo yield | 0.00% | 0.71% |
| Income per year on $10k | $0 | $71 |
| YTD | +16.6% | −3.2% |
| 1 year | +20.1% | −3.4% |
| 3 years · per year | +16.2% | — |
| 5 years · per year | — | — |
| Worst drop · 1Y | −18.3% | −15.8% |
| Volatility · 1Y | 23.4% | 19.3% |
| Holdings | 63 | 50 |
| Assets | $52M | $127M |
| Leverage | None | None |
| Since | 2020 | 2025 |
Highlighted = best in the row. Returns include dividends.